Document is current
Any future updates will be listed below
-
Authors
Guo, Longhua
Boocock, James
Hilt, Evann E.
Chandrasekaran, Sukantha
Zhang, Yi
Munugala, Chetan
Sathe, Laila
Alexander, Noah
Arboleda, Valerie A.
Flint, Jonathan
Eskin, Eleazar
Luo, Chongyuan
Yang, Shangxin
Garner, Omai B.
Yin, Yi
Bloom, Joshua S.
Kruglyak, Leonid
-
Funding
Funding for this research was provided by:
Helen Hay Whitney Foundation
UCLA David Geffen School of Medicine’s Dean’s Office
the Fast Grants. Inc
Jane Semel
National Institute for Health
Damon Runyon Cancer Research Foundation
Howard Hughes Medical Institute
- License Information
-
More Information
Article History
Received: 14 April 2021
Accepted: 15 March 2022
First Online: 4 April 2022
Declarations
:
: All patient samples used in our study were deidentified. All samples were obtained with UCLA IRB approval []. Samples were not obtained from patients/subjects specifically for the present study.
: Not applicable.
: JSB consults for and holds equity in Octant Inc. LG, JB, EEH, SC, YZ, CM, LS, NA, VAA, JF, EE, CL, SY, OBG, YY, LK declare no conflicts of interest.
